Display options
Cite
Barbosa Dos Santos G, Machado Rodrigues MJ, Gonçalves EM, et al. Melatonin reduces oxidative stress and cardiovascular changes induced by stanozolol in rats exposed to swimming exercise. Eurasian J Med. 2013;45(3):155-62doi: 10.5152/eajm.2013.33.
Barbosa Dos Santos, G., Machado Rodrigues, M. J., Gonçalves, E. M., Cintra Gomes Marcondes, M. C., & Areas, M. A. (2013). Melatonin reduces oxidative stress and cardiovascular changes induced by stanozolol in rats exposed to swimming exercise. The Eurasian journal of medicine, 45(3), 155-62. https://doi.org/10.5152/eajm.2013.33
Barbosa Dos Santos, Gustavo, et al. "Melatonin reduces oxidative stress and cardiovascular changes induced by stanozolol in rats exposed to swimming exercise." The Eurasian journal of medicine vol. 45,3 (2013): 155-62. doi: https://doi.org/10.5152/eajm.2013.33
Barbosa Dos Santos G, Machado Rodrigues MJ, Gonçalves EM, Cintra Gomes Marcondes MC, Areas MA. Melatonin reduces oxidative stress and cardiovascular changes induced by stanozolol in rats exposed to swimming exercise. Eurasian J Med. 2013 Oct;45(3):155-62. doi: 10.5152/eajm.2013.33. PMID: 25610273; PMCID: PMC4261421.
Copy Download .nbib Format: NLM
Share it on

Eurasian J Med. 2013 Oct;45(3):155-62. doi: 10.5152/eajm.2013.33.

Melatonin reduces oxidative stress and cardiovascular changes induced by stanozolol in rats exposed to swimming exercise.

The Eurasian journal of medicine

Gustavo Barbosa Dos Santos, Marcelo José Machado Rodrigues, Estela Maria Gonçalves, Maria Cristina Cintra Gomes Marcondes, Miguel Arcanjo Areas

Affiliations

  1. Department of Structural and Functional Biology, Institute of Biology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.

PMID: 25610273 PMCID: PMC4261421 DOI: 10.5152/eajm.2013.33

Abstract

OBJECTIVE: Anabolic-androgenic steroids (AAS) are nominated for clinical use to promote protein synthesis in many therapeutic conditions. However, the indiscriminate use of AAS is related to hazardous cardiac disturbances and oxidative stress. We designed a study to investigate whether prolonged treatment with high doses of stanozolol modifies the activities of some antioxidant enzymes in the heart in sedentary and trained rats and whether this treatment causes alterations of cardiovascular parameters. In addition, the effectiveness of melatonin as an antioxidant and as a modulator of the cardiovascular side effects of stanozolol (STA) treatment was analyzed.

MATERIALS AND METHODS: Thirty male Wistar rats were divided into the following six groups: sedentary (S), stanozolol sedentary (SS), stanozolol-melatonin sedentary (SMS), trained (T), stanozolol trained (ST) and stanozolol-melatonin trained (SMT). The stanozolol-treatment rats received 5 mg.kg(-1) by subcutaneous injection before each exercise session (5 d.wk(-1), i.e., 25 mg.kg(-1).wk(-1)), while control groups received only saline solution injection. The melatonin-treatment groups received intraperitoneal injections of melatonin (10 mg.kg(-1)), 5 d.wk(-1) for 6 wk. Electrocardiography, blood pressure and antioxidant enzyme activity measurements were performed at the end of the experimental period for cardiac function and molecular assessment.

RESULTS: This is the first time that the in vivo effects of melatonin treatment on stanozolol-induced cardiovascular side effects have been studied. Stanozolol induced bradycardia and significantly increased cardiac superoxide dismutase and catalase activities. Trained stanozolol-treated rats experienced an increase in blood pressure and relative heart weight, and they developed left cardiac axis deviation. Although melatonin did not prevent cardiac hypertrophy in exercised stanozolol-treated animals, it maintained blood pressure and cardiac catalase activity, and it prevented stanozolol-induced cardiac electrical axis deviation.

CONCLUSION: In conclusion, under our experimental conditions, chronic stanozolol administration induced mild cardiovascular side effects that were partly attenuated by melatonin treatment. However, these results showed that the combination of melatonin and exercise could minimize the stanozolol side effects in the cardiovascular system.

Keywords: Stanozolol; anabolic effects; electrocardiogram; exercise; melatonin; oxidative stress

References

  1. J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):687-95 - PubMed
  2. Int J Legal Med. 2007 Jan;121(1):48-53 - PubMed
  3. Heart. 2004 May;90(5):496-501 - PubMed
  4. Drug Alcohol Depend. 2008 Nov 1;98 (1-2):1-12 - PubMed
  5. J Auton Nerv Syst. 2000 Jul 3;81(1-3):16-24 - PubMed
  6. J Steroid Biochem Mol Biol. 2006 Jun;99(4-5):223-30 - PubMed
  7. Physiol Res. 2007;56(6):671-84 - PubMed
  8. J Steroid Biochem Mol Biol. 2003 Dec;87(4-5):269-77 - PubMed
  9. Neurochem Int. 2006 Sep;49(4):387-92 - PubMed
  10. J Pineal Res. 2003 Sep;35(2):75-9 - PubMed
  11. Heart. 2004 May;90(5):473-5 - PubMed
  12. Arq Bras Cardiol. 2008 Apr;90(4):232-8 - PubMed
  13. J Steroid Biochem Mol Biol. 2005 Jan;93(1):43-8 - PubMed
  14. Anal Biochem. 1970 Mar;34:30-8 - PubMed
  15. Proc Soc Exp Biol Med. 1999 Dec;222(3):283-92 - PubMed
  16. Endocrinology. 2000 Feb;141(2):487-97 - PubMed
  17. J Clin Endocrinol Metab. 2004 Oct;89(10):5245-55 - PubMed
  18. Acta Physiol Scand. 2004 Feb;180(2):157-66 - PubMed
  19. Eur J Appl Physiol. 2002 Oct;87(6):550-5 - PubMed
  20. J Hypertens Suppl. 2009 Aug;27(6):S5-10 - PubMed
  21. Cardiovasc J S Afr. 2005 Jan-Feb;16(1):21-8 - PubMed
  22. Braz J Med Biol Res. 2004 Dec;37(12):1909-17 - PubMed
  23. J Clin Endocrinol Metab. 1999 Aug;84(8):2705-11 - PubMed
  24. Exp Clin Cardiol. 2003 Winter;8(4):201-5 - PubMed
  25. J Pineal Res. 2005 Sep;39(2):99-104 - PubMed
  26. J Lab Clin Med. 1975 Feb;85(2):337-41 - PubMed
  27. Clin Dermatol. 2009 Mar-Apr;27(2):202-9 - PubMed
  28. J Invest Dermatol. 1998 Dec;111(6):1193-7 - PubMed
  29. Am J Physiol Renal Physiol. 2006 Aug;291(2):F495-502 - PubMed
  30. J Cardiovasc Pharmacol. 2001 Nov;38(5):754-63 - PubMed

Publication Types